BioFire Test for COVID-19 Detection
Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses
Recruiting
Observational Study
Coronavirus
Respiratory Infection
COVID
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- BioFire Defense LLC · Industry
Who this trial is looking for
This trial is looking for patients who have leftover samples from COVID-19 testing. Participants will help evaluate the accuracy of a new test for detecting coronaviruses.
Are You a Good Fit for This Trial?
You may be able to join if
- I have a leftover sample from a standard respiratory test.
- My sample has been stored properly within time limits.
- I have at least 1.7 mL of sample left after testing.
You may not be able to join if
- My sample cannot be tested because it wasn't stored correctly.
- My sample does not have enough volume for testing.
- I do not know the type of transport medium my sample is in.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The Biomedical Advanced Research and Development Authority (BARDA) has contracted BioFire Defense (BFDf) to develop the BioFire Emerging Coronavirus (ECoV) Panel, a nucleic acid test capable of detecting coronaviruses from nasopharyngeal swab (NPS) in transport medium.
This study aims to evaluate the diagnostic accuracy of the assays comprising the BioFire ECoV Panel. It is hypothesized that the …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Specimen is residual NPS in transport medium (VTM or UTM) left over from standard of care testing under clinician order for respiratory pathogen analysis.
* Specimen has been held at room temperature for less than or equal to 4 hours or 4°C for less than or equal to 72 hours b…
Contacts